A detailed history of Continuum Advisory, LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Continuum Advisory, LLC holds 874 shares of BSX stock, worth $72,865. This represents 0.01% of its overall portfolio holdings.

Number of Shares
874
Previous 606 44.22%
Holding current value
$72,865
Previous $41,000 63.41%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 19, 2024

BUY
$67.33 - $77.71 $18,044 - $20,826
268 Added 44.22%
874 $67,000
Q1 2024

May 10, 2024

BUY
$57.6 - $68.62 $34,905 - $41,583
606 New
606 $41,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $119B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Continuum Advisory, LLC Portfolio

Follow Continuum Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Continuum Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Continuum Advisory, LLC with notifications on news.